{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259332214", "close" : "1259344814", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
businesswire

Cardiovascular Systems to Present at Two September Investor Conferences

Robert W. Baird Health Care Conference on Thursday, September 10, 2009 at 10:30 a.m. EST
Thomas Weisel Partners Health Care Conference on Friday, September 11, 2009 at 9:45 a.m. EST

Live Webcasts Available for Both Conferences


  • Press Release
  • Source: Cardiovascular Systems, Inc.
  • On 1:07 pm EDT, Wednesday September 2, 2009

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (Nasdaq: CSII - News), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at two upcoming health care conferences: the Robert W. Baird Health Care Conference at the Four Seasons Hotel in New York, and the Thomas Weisel Partners Health Care Conference at the Four Seasons Hotel in Boston. President and Chief Executive Officer David L. Martin and Chief Financial Officer Laurence L. Betterley will provide an overview of the company and its strategies for growth.

 

WHEN:

Robert W. Baird Health Care Conference

Thursday, Sept. 10; 10:30 a.m. EST
Four Seasons Hotel
New York
 

Thomas Weisel Partners Health Care Conference

Friday, Sept. 11; 9:45 a.m. EST
Four Seasons Hotel
Boston
 

WEBCAST:

To listen to a live webcast of either presentation, go to the investor information section of the company’s Web site, www.csi360.com, and click on the respective webcast icon.

 

If you have any difficulty accessing the webcast, please contact Mick Forgey: (612) 455-1789; mforgey@psbpr.com

 

Related Quotes

SymbolPriceChange
CSII5.00-0.13
Chart for Cardiovascular Systems, Inc.
{"s" : "csii","k" : "c10,l10,p20,t10","o" : "","j" : ""}

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc. is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease. The company's Diamondback 360°® Peripheral Arterial Disease System is capable of treating a broad range of plaque types both above and below the knee, including calcified vessel lesions, and addresses many of the limitations associated with existing treatment alternatives. In August 2007, the U.S. FDA granted 510(k) clearance for the use of the Diamondback 360° as a therapy for PAD (peripheral arterial disease), and CSI commenced a U.S. product launch in September 2007. The Diamondback 360° system has been adopted by nearly 600 hospitals across the United States. For more information visit the company's Web site at www.csi360.com.

Contact:

Cardiovascular Systems, Inc.:
Investor Relations, 651-259-2800
or
Padilla Speer Beardsley:
Nancy A. Johnson, 612-455-1745
njohnson@psbpr.com

Sponsored Links

Copyright © 2009 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.